BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 10, 2025
Breaking News: 100 days of uncertainty
See today's BioWorld Science
Home
» TWi Biotechnology reports interim data from phase II AC-201 CR study in gout patients
To read the full story,
subscribe
or
sign in
.
TWi Biotechnology reports interim data from phase II AC-201 CR study in gout patients
Dec. 29, 2015
BioWorld Science
Endocrine/metabolic
